{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:38:59Z","timestamp":1792762739213,"version":"4.5.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"21","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Analgosedation is the standard of care for managing mechanically ventilated critically ill patients. Most sedative medications are lipophilic, with increased volume of distribution in patients with obesity; however, data about dosing these drugs in critically ill patients with obesity are limited. In 2022, our institution changed to an ideal body weight (IBW) dosing strategy for all weight-based continuous infusions of analgesia and sedation agents, including fentanyl, ketamine, propofol, and dexmedetomidine. This study evaluated whether utilizing IBW dosing for critically ill patients with obesity results in decreased analgesic requirements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a single-center, retrospective, observational cohort study that included critically ill adult patients with a body mass index (BMI) of greater than 30 kg\/m2 receiving analgosedation with continuous fentanyl from January 1 to March 31, 2020 (actual body weight [ABW] group) and from January 1 to March 31, 2024 (IBW group). Patients were excluded if they required deep sedation or mechanical circulatory support, had a history of chronic opioid use or opioid use disorder, or had a positive COVID-19 result. The primary outcome was cumulative morphine milligram equivalent (MME) requirements during the fentanyl continuous infusion. Secondary outcomes included the cumulative doses of sedation and duration of mechanical ventilation, as well as intensive care unit (ICU) and hospital length of stay (LOS). Efficacy was evaluated via RASS and CPOT score and by as-needed opioid and benzodiazepine requirements in MME and midazolam equivalents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-six patients in the ABW group and 31 patients in the IBW group were included. The median BMI was similar (ABW group, 35.3 kg\/m2; IBW group, 34.9 kg\/m2; P = 0.83). The IBW group had significantly lower median cumulative intravenous MME requirements (ABW group, 931.2 mg; IBW group, 537.9 mg; P = 0.04). For the secondary outcomes, the cumulative MME requirements for fentanyl differed between the dosing strategies (ABW group, 914.1; IBW group, 485.8; P = 0.03), but no differences were found for other sedatives, as-needed opioids or benzodiazepines, duration of mechanical ventilation, ICU LOS, or hospital LOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Utilizing IBW dosing decreased cumulative opioid requirements in critically ill patients with obesity without resulting in increased doses of other sedatives or as-needed medications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxag159","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T11:33:31Z","timestamp":1780832011000},"page":"e805-e813","source":"Crossref","is-referenced-by-count":0,"title":["Impact of ideal vs actual body weight on analgesic and sedative requirements in critically ill patients with obesity"],"prefix":"10.1093","volume":"83","author":[{"given":"Melanie","family":"Datt","sequence":"first","affiliation":[{"name":"University of Georgia College of Pharmacy , Augusta, GA , and , Augusta, GA ,","place":["USA"]},{"name":"Wellstar MCG Health , Augusta, GA , and , Augusta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N","family":"Taylor","sequence":"additional","affiliation":[{"name":"Wellstar MCG Health , Augusta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Forehand","sequence":"additional","affiliation":[{"name":"Piedmont Healthcare, Augusta, GA, and University of Georgia College of Pharmacy , Augusta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Pearman","sequence":"additional","affiliation":[{"name":"(PharmD student), University of Georgia College of Pharmacy , Augusta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Lopez","sequence":"additional","affiliation":[{"name":"University of Georgia College of Pharmacy , Augusta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke A","family":"Smith","sequence":"additional","affiliation":[{"name":"Wellstar MCG Health , Augusta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"issue":"9","key":"2026102308565135400_zxag159-B1","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","article-title":"Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU","volume":"46","author":"Devlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"4","key":"2026102308565135400_zxag159-B2","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1345\/aph.1Q525","article-title":"Analgosedation: a paradigm shift in intensive care unit sedation practice","volume":"46","author":"Devabhakthuni","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"8","key":"2026102308565135400_zxag159-B3","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1111\/bcp.14735","article-title":"Effect of lipophilicity on drug distribution and elimination: influence of obesity","volume":"87","author":"Bruno","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2026102308565135400_zxag159-B4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00000542-200409000-00008","article-title":"Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight (\u201cpharmacokinetic mass\u201d)","volume":"101","author":"Shibutani","year":"2004","journal-title":"Anesthesiology"},{"issue":"6","key":"2026102308565135400_zxag159-B5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00540-017-2399-y","article-title":"Pharmacokinetic and pharmacodynamics of intravenous dexmedetomidine in morbidly obese patients undergoing laparoscopic surgery","volume":"31","author":"Xu","year":"2017","journal-title":"J Anesth"},{"issue":"1","key":"2026102308565135400_zxag159-B6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/CCM.0000000000001347","article-title":"Population pharmacokinetics of fentanyl in the critically ill","volume":"44","author":"Choi","year":"2016","journal-title":"Crit Care Med"},{"issue":"6","key":"2026102308565135400_zxag159-B7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/0018578719851452","article-title":"Adjusted vs total body weight\u2013based dosing of sedation and analgesia used in the intensive care unit","volume":"55","author":"Yeary","year":"2020","journal-title":"Hosp Pharm"},{"issue":"1","key":"2026102308565135400_zxag159-B8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/08971900211021578","article-title":"Evaluation of dexmedetomidine dosing in obese critically ill patients","volume":"36","author":"Atyia","year":"2023","journal-title":"J Pharm Pract"},{"key":"2026102308565135400_zxag159-B9","first-page":"650","article-title":"Gentamicin therapy","volume":"8","author":"Devine","year":"1974","journal-title":"Drug Intell Clin Pharm"},{"issue":"9607","key":"2026102308565135400_zxag159-B10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(08)60105-1","article-title":"Efficacy and safety of paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled Trial): a randomised controlled trial","volume":"371","author":"Girard","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"2026102308565135400_zxag159-B11","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bja.2021.11.040","article-title":"Multicentre analysis of practice patterns regarding benzodiazepine use in cardiac surgery","volume":"128","author":"Janda","year":"2022","journal-title":"Br J Anaesth"},{"issue":"2","key":"2026102308565135400_zxag159-B12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2026102308565135400_zxag159-B13","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2026102308565135400_zxag159-B14"},{"issue":"2","key":"2026102308565135400_zxag159-B15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1365-2125.2004.02157.x","article-title":"What is the best size descriptor to use for pharmacokinetic studies in the obese?","volume":"58","author":"Green","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"1-2","key":"2026102308565135400_zxag159-B16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1177\/0310057X211070008","article-title":"The complications of opioid use during and post-intensive care admission: a narrative review","volume":"50","author":"Moran","year":"2022","journal-title":"Anaesth Intensive Care"},{"issue":"4","key":"2026102308565135400_zxag159-B17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1164\/rccm.201912-2503OC","article-title":"New opioid use after invasive mechanical ventilation and hospital discharge","volume":"202","author":"Wunsch","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2026102308565135400_zxag159-B18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ccrj.2023.11.004","article-title":"Hospital and long-term opioid use according to analgosedation with fentanyl vs. morphine: findings from the ANALGESIC trial","volume":"26","author":"Casamento","year":"2024","journal-title":"Crit Care Resusc"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag159\/68495248\/zxag159.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/21\/e805\/68495248\/zxag159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/21\/e805\/68495248\/zxag159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:56:58Z","timestamp":1792760218000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/83\/21\/e805\/8704533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":18,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2026,6,9]]},"published-print":{"date-parts":[[2026,10,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxag159","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11,1]]},"published":{"date-parts":[[2026,6,9]]}}}